Total Payments
$9,767
2023 Payments
$30.15
Companies
11
Transactions
63
Medicare Patients
1,837
Medicare Billing
$605,054
Payment Breakdown by Category
Education$8,062 (82.5%)
Food & Beverage$1,705 (17.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $8,062 | 3 | 82.5% |
| Food and Beverage | $1,705 | 60 | 17.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $8,679 | 9 | $0 (2022) |
| Merck Sharp & Dohme LLC | $429.31 | 26 | $0 (2022) |
| Genentech USA, Inc. | $216.09 | 8 | $0 (2019) |
| Seagen Inc. | $100.09 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $97.81 | 6 | $0 (2022) |
| TESARO, Inc. | $76.33 | 2 | $0 (2018) |
| Abbott Laboratories | $61.92 | 1 | $0 (2022) |
| Amgen Inc. | $38.33 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $30.15 | 1 | $0 (2023) |
| Clovis Oncology, Inc. | $23.72 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.15 | 1 | Novartis Pharmaceuticals Corporation ($30.15) |
| 2022 | $8,476 | 11 | Intuitive Surgical, Inc. ($8,300) |
| 2021 | $123.36 | 7 | Merck Sharp & Dohme Corporation ($59.60) |
| 2020 | $132.00 | 4 | Intuitive Surgical, Inc. ($77.78) |
| 2019 | $270.59 | 11 | Intuitive Surgical, Inc. ($90.02) |
| 2018 | $571.05 | 20 | Intuitive Surgical, Inc. ($210.91) |
| 2017 | $163.40 | 9 | AstraZeneca Pharmaceuticals LP ($40.42) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $30.15 | General |
| 12/14/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 12/14/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 11/16/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2022 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Oncology | ||||||
| 10/12/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 10/12/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 10/12/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Oncology | ||||||
| 06/08/2022 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Oncology | ||||||
| 03/16/2022 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Oncology | ||||||
| 02/07/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: ONCOLOGY | ||||||
| 01/05/2022 | Abbott Laboratories | PROCLAIM (Device) | Education | In-kind items and services | $61.92 | General |
| Category: Neuromodulation | ||||||
| 12/15/2021 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Oncology | ||||||
| 12/01/2021 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Oncology | ||||||
| 11/03/2021 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $22.62 | General |
| 09/29/2021 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: OB/GYN | ||||||
| 07/09/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: ONCOLOGY | ||||||
| 03/24/2020 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $77.78 | General |
| Category: SURGERY | ||||||
| 12/04/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 20 | 516 | 6,391 | $987,606 | $209,066 |
| 2021 | 24 | 710 | 5,402 | $1.0M | $288,852 |
| 2020 | 20 | 611 | 14,526 | $459,283 | $107,135 |
Total Patients
1,837
Total Services
26,319
Medicare Billing
$605,054
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2022 | 16 | 768 | $542,496 | $97,821 | 18.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 67 | 173 | $81,500 | $25,238 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 270 | $93,440 | $24,730 | 26.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 21 | 199 | $89,642 | $23,130 | 25.8% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 15 | 15 | $54,296 | $12,217 | 22.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 18 | 344 | $25,496 | $4,652 | 18.2% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 13 | 80 | $16,502 | $4,562 | 27.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 14 | 124 | $11,472 | $3,056 | 26.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $9,584 | $2,275 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $8,630 | $2,044 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 26 | $6,006 | $2,000 | 33.3% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 11 | 62 | $6,244 | $1,594 | 25.5% |
| 56820 | Exam of external female genitals using an endoscope | Office | 2022 | 11 | 15 | $5,655 | $1,437 | 25.4% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2022 | 11 | 603 | $8,337 | $1,311 | 15.7% |
| 96377 | Application of on-body injector for under skin injection | Office | 2022 | 15 | 58 | $2,898 | $930.77 | 32.1% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2022 | 16 | 1,080 | $18,470 | $874.78 | 4.7% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2022 | 15 | 50 | $3,350 | $827.80 | 24.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 17 | 2,270 | $3,260 | $216.39 | 6.6% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2022 | 11 | 150 | $170.00 | $84.42 | 49.7% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2022 | 12 | 74 | $158.00 | $66.60 | 42.2% |
| J2505 | Injection, pegfilgrastim, 6 mg | Office | 2021 | 16 | 72 | $478,944 | $153,395 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 217 | 334 | $114,896 | $32,308 | 28.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 92 | 215 | $100,405 | $30,581 | 30.5% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 26 | 179 | $78,402 | $22,215 | 28.3% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 18 | 18 | $66,460 | $13,674 | 20.6% |
About Dr. Michael Lowe, MD
Dr. Michael Lowe, MD is a Gynecologic Oncology healthcare provider based in Oak Lawn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922037787.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Lowe, MD has received a total of $9,767 in payments from pharmaceutical and medical device companies, with $30.15 received in 2023. These payments were reported across 63 transactions from 11 companies. The most common payment nature is "Education" ($8,062).
As a Medicare-enrolled provider, Lowe has provided services to 1,837 Medicare beneficiaries, totaling 26,319 services with total Medicare billing of $605,054. Data is available for 3 years (2020–2022), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology, Gynecologic Oncology
- Location Oak Lawn, IL
- Active Since 07/02/2006
- Last Updated 08/25/2020
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1922037787
Products in Payments
- Da Vinci Surgical System (Device) $8,679
- KEYTRUDA (Biological) $309.19
- Avastin (Biological) $216.09
- LYNPARZA (Biological) $103.97
- TIVDAK (Biological) $77.47
- PROCLAIM (Device) $61.92
- LYNPARZA (Drug) $57.39
- ZEJULA (Drug) $43.44
- FASLODEX (Drug) $40.42
- Neulasta (Biological) $38.33
- VARUBI (Drug) $32.89
- Rubraca (Drug) $23.72
- OVA1 (Device) $14.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Oak Lawn
Alfred Guirguis, D.o, D.O
Gynecologic Oncology — Payments: $95,309
Gynecologic Oncology $95,309
Yvonne Collins, Md, Facog, MD, FACOG
Gynecologic Oncology — Payments: $9,236
Gynecologic Oncology $9,236
Dr. Nikki Neubauer, M.d, M.D
Gynecologic Oncology — Payments: $1,051
Gynecologic Oncology $1,051
Molly Ramaswami, Md, MD
Gynecologic Oncology — Payments: $935.95
Gynecologic Oncology $935.95
Carrie Mcilwain, Md, MD
Gynecologic Oncology — Payments: $842.15
Gynecologic Oncology $842.15